Halma plc (HLMAF) Stock
Established in 1894 and based in Amersham, UK, Halma plc is a global group of companies delivering innovative technological products and services across three primary areas: safety, health, and environmental protection. These operations are structured into three distinct segments: Safety, Environmental & Analysis, and Medical.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Halma plc
Established in 1894 and based in Amersham, UK, Halma plc is a global group of companies delivering innovative technological products and services across three primary areas: safety, health, and environmental protection. These operations are structured into three distinct segments: Safety, Environmental & Analysis, and Medical. The Safety division focuses on preventing harm and managing risk; its offerings include advanced fire detection and suppression systems, secure elevator operation technologies, various security sensors, solutions for managing human and vehicular traffic, specialized interlocks to ensure safe critical process control, and protective measures against explosions and corrosion. This segment caters to a broad range of industries, such as elevator safety, fire management, access control for industrial settings, secure storage and material transfer, and general people and vehicle movement. Within the Environmental & Analysis segment, Halma develops and supplies technologies for understanding and protecting our surroundings, encompassing sophisticated optical and imaging systems, comprehensive monitoring solutions for water, air, and various gases, devices for identifying dangerous gases and assessing air quality, and advanced systems for water purification and analysis. Key markets for this segment include optical diagnostics, water management, gas sensing, and overall environmental observation. The Medical division is dedicated to supporting healthcare and life sciences; it delivers essential fluidic components for medical diagnostic equipment and OEMs, along with laboratory instruments and systems that generate vital patient health data to guide treatment decisions. This segment also provides technologies and solutions that facilitate in-vitro diagnostics, accelerate life-science research and development, and improve patient outcomes across diverse clinical fields. Its primary markets are life sciences, health evaluation, and therapeutic interventions.
Halma plc is headquartered in GB.
Halma plc (HLMAF) stock trades at $48.83 with a market capitalization of $18.44B. The stock is valued at a price-to-earnings (P/E) ratio of 37.37, price-to-book of 6.41, price-to-sales of 5.36. Over the past 52 weeks the stock has ranged between $41.77 and $66.22, and currently trades 26.3% below its 52-week high. It pays a dividend yielding 0.84%.
On profitability, Halma plc generates a return on equity (ROE) of 17.92%, above the typical market average, return on capital employed of 16.48%, an operating margin of 20.36%, a net profit margin of 14.42%.
In its most recent fiscal year, Halma plc reported annual revenue of $2.6B, net profit of $373.0M, revenue has compounded at 14.5% a year over the last five years, profit at 12.9% a year.
The balance sheet shows a debt-to-equity ratio of 0.42 — a conservative balance sheet with little leverage risk, a current ratio of 2.14, total assets of $3.7B, $144.0M in cash and equivalents.
HLMAF has an average daily trading volume of 11,113 shares, a beta of 0.98.
Official website: www.halma.com